i UBUNTU | CLINICAL DEVELOPMENT SERVICE

Who We Are

A pioneering yet simple to adopt (minimalistic) approach to designing & executing drug development program.

1-866-535-7444 (toll free) OR info@ubunturesearch.life

Dimension-T™*

image

Dimension-T™*

  • A dynamic, sustainable, and scalable framework for clinical development operations. We've built this platform around the concept of shared infrastructure, offering on-demand and subscription-based solutions that streamline the clinical trial process and provide tailored technology platforms.
    • Mission
  • We're assembling the industry's foremost strategic and core talent , boasting a collective experience spanning over two centuries. Our singular objective is to deliver Time-Value and unlock Profitable Synergies, particularly for emerging biotech firms and their valued investors.
  • We're now inviting visionary investors to join us in revolutionizing the clinical development landscape. With Dimension-T™* , we're poised to drive innovation, efficiency, and success in the biotech sector.
  • Are you ready to be a part of this transformative journey? Let's connect and explore opportunities together!

Ubuntu's Dimension-T™* Subscription Model for Biotech

Current Operating Model

  • Over Hire - Time And Scale

Ubuntu Clinical Development as a service (CDaas) Subscription Model

  • Strategic & Core Talent
  • Fractional Resourcing

Current Operating Model

  • Originate From Scratch

Ubuntu Clinical Development as a service (CDaas) Subscription Model

  • Ready to Deploy & customized

Current Operating Model

  • Multiple Tech Solutions

Ubuntu Clinical Development as a service (CDaas) Subscription Model

  • Functionally Integrated & GxP compliant (patientlevel to portfolio level) to have single version of truth
image

Dimension-T™*solution: Our Customized Clinical Development As A Service (CDaaS) Subscription Solution for Biotech and Investors.

  • Dimension-T™* is a custom solution for robust clinical development strategies including cost reduction, efficient resource allocation, and dynamic clinical research capabilities to accelerate drug development.
  • Our solution is an agile, sustainable, scalable, and efficient clinical development operations framework. It is developed on the premise of a shared infrastructure of on-demand/subscription-oriented solutions to streamline clinical trial processes & integration of clinical trial technology solutions.
  • This results in rapid & efficient set-up of clinical trials and high-quality development of clinical stage assets (i.e. drugs). This enables companies to focus their resources on best in class clinical development and business solutions.

Dimension-T™*
Academics
Early-Stage Biopharmas
Mid-Stage Biopharmas
Mature Biopharmas

Design Smart

Develop Strong

Drive Forward

Determine Success
Conceptualize and validate early-stage clinical design Access (from day 1) to a functional clinical development organization and partnered CROs Develop and operationalize full scope clinical development plan objectives Integrate RWD with aggregated clinical data sets for label extensions and to enhance life cycle management
Operationalize an "academic-center equivalent" incubation Realize significant time acceleration via CDaaS' modular approach Address gaps and blind spots to reduce risks and threats that still exist to full commercialization Improve patient access to middle and lowincome geographies
Maximize asset valuation into biopharma spinof Control and mitigate uncertainties and escalating costs of early-stage clinical development Generate data insights and governance to prepare for asset partnership/transition Mitigate commercial launch risks and enhance KOL engagement

What can Biopharma learn from successes of other industries?

Biotech's must move

form BUILD / OUTSOURCING FOCUS

to A CURATED SUBSCRIPTION MODEL

From Legacy Operating Model
A Dedicated Infrastructure
Conventional asset development
Committed Cost Structure
To Knowledge/ Research Operating Model
On Demand Ecosystem
Pipeline Guided Agility
On / Off Capability

Transforming science into medicines by
architecting drug development ecosystem

* Trademark Pending

Quick Links

Information

Copyright © 2025 Ubuntu. All Rights Reserved | Design by Ezephyr